Edition:
United States

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.76USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$1.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,943
52-wk High
$3.91
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.002
FY 2017 Dec '17 0.00 0.000
Sep '17 0.003
Jun '17 -0.003
Mar '17 -0.003
FY 2016 Dec '16 0.00 -0.003
Sep '16 -0.006
Jun '16 0.00 -0.010
Mar '16 -0.011
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 8.15 95.67 30.17
P/E High - Last 5 Yrs. 65.61 268.68 47.22
P/E Low - Last 5 Yrs. 65.61 94.38 24.76
Beta 0.02 0.78 0.85
Price to Sales (TTM) -- 251.80 7.96
Price to Book (MRQ) 0.14 12.51 3.68
Price to Tangible Book (MRQ) 1.42 22.18 5.57
Price to Cash Flow (TTM) -- 61.34 20.80
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.38 1.79
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.50 -6.02
Payout Ratio(TTM) -- 6.29 46.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 157.04 7.11
Sales (TTM) vs TTM 1 Yr. Ago -- 90.91 11.85
Sales - 5 Yr. Growth Rate -- 24.11 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 158.22 91.80 23.72
EPS (TTM) vs TTM 1 Yr. Ago 109.46 -- --
EPS - 5 Yr. Growth Rate -- 23.11 7.49
Capital Spending - 5 Yr. Growth Rate -- 36.56 8.05

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.50
Current Ratio (MRQ) 26.07 5.43 3.54
LT Debt to Equity (MRQ) -- 19.83 11.28
Total Debt to Equity (MRQ) -- 23.67 14.23
Interest Coverage (TTM) -2.18 -188.31 32.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.15 55.18
Gross Margin - 5 Yr. Avg. -- 52.69 53.35
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -191.22 15.81
Operating Margin (TTM) -- -1,104.16 -2.55
Operating Margin - 5 Yr. Avg. -- -204.63 10.94
Pre-Tax Margin (TTM) -- -989.95 -0.67
Pre-Tax Margin - 5 Yr. Avg. -- -205.61 11.10
Net Profit Margin (TTM) -- -981.23 -3.87
Net Profit Margin - 5 Yr. Avg. -- -203.21 7.45
Effective Tax Rate (TTM) -- 12.10 20.32
Effective Tax Rate - 5 Yr. Avg. -- 18.73 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,056,061 723,095,676
Net Income/Employee (TTM) -- -5,576,115 84,116,797
Receivable Turnover (TTM) -- 6.52 5.40
Inventory Turnover (TTM) -- 2.27 3.53
Asset Turnover (TTM) 0.00 0.43 0.84

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 15.06 2.18 10.09
Return on Assets - 5 Yr. Avg. -30.36 2.43 10.96
Return on Investment (TTM) 15.93 3.33 12.67
Return on Investment - 5 Yr. Avg. -36.94 1.79 14.16
Return on Equity (TTM) 22.08 2.31 14.86
Return on Equity - 5 Yr. Avg. -35.99 -7.00 15.52
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 82.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for X T L Biopharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.63%
# of Holders: 6
Total Shares Held: 238,137
3 Mo. Net Change: 60,854
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.